Nearly four in five PWID in Oakland and San Francisco recently witnessed an overdose. Witnesses are at greater risk of non-fatal overdose and may be the first to respond when those they inject with overdose. Targeting naloxone distributions to PWID who are characteristically more likely to witness overdoses may prevent additional drug-related deaths.
Suprasert et al. (Sun,) studied this question.